Director, Global ; RWE Global Commercial Strategy Organization; GCSO

Job Function

Data Analytics & Computational Sciences

Data Science

People Leader

Raritan, New Jersey, United States of America

Director, Global Real‑World Evidence (RWE) – Global Commercial Strategy Organization (GCSO).

This role is responsible for developing and executing industry‑leading RWE strategies across J&J’s Global Commercial Strategy Organization. Working alongside the Senior Director of Global RWE for Oncology and other GCSO leaders, the Director focuses on enhancing global go‑to‑market launch planning by making strategic decisions and investments based on RWE insights.

The role leverages deep industry knowledge and cross‑functional insights to identify opportunities for RWE growth within GCSO and beyond, implementing effective strategies into action. Collaboration is essential across global medical affairs, market access, commercial teams, and external partners such as regional medical affairs, commercial groups, US Real World Value & Evidence, Global Epidemiology, J&J Technology Data Sciences, and R&D Data Science.

• Lead the global RWE strategy and execution for key oncology assets: define research questions, develop study protocols, study design/methodology, real‑world data selection and analysis, results dissemination, and communication to support medical adoption and product differentiation across regions.
• Serve as the GRWE representative on cross‑functional franchise teams, partnering closely with Global Medical Affairs, Market Access, and other stakeholders; act as the RWE subject matter expert in Global Integrated Evidence Generation Plan (IEGP) and oversee global real‑world data and evidence generation strategies.
• Advance RWE capabilities and best practices by sharing latest developments, delivering technical training, strengthening internal expertise in advanced RWE methods, and supporting governance, quality standards, and compliance for global and local RWE activities.
• Lead Evidence Lab coordination to drive concept development, stakeholder alignment, and prioritization of RWE opportunities within the Global IEGP process.
• Ensure full compliance with regulatory, legal, and commercial regulations in research conduct, data usage, and scientific communication.
• Support implementation and provide guidance when needed across regional and local levels.

• Master’s degree in a quantitative field (e.g., epidemiology, HEOR, pharmacoepidemiology, biostatistics);
  PhD preferred.
• Minimum 6 years of relevant experience in pharma, biotech, or healthcare consulting.
• Demonstrated expertise in observational research (prospective and retrospective) across study design, conduct, analysis, and reporting.
• Experience executing RWE studies using diverse real‑world data sources; multi‑country experience preferred.
• Understanding of global healthcare delivery, reimbursement, and payer dynamics desirable.
• Strong communication, storytelling, and presentation skills; ability to translate complex methods and statistics for both technical and non‑technical stakeholders.
• Highly motivated, intellectually curious, and skilled at managing multiple priorities in a fast‑paced environment.
• Proven experience working effectively in a matrixed, cross‑functional team environment.
• Proficiency in standard office applications (Word, Excel, PowerPoint) and familiarity with statistical programming tools (SAS, R, Python).

• Experience in oncology therapy area.
• Experience with programming in major statistical analysis systems.
• Good understanding of evidence‑based medicine and comparative effectiveness analyses in healthcare research.
• Experience managing analytical/statistical activities with external service providers.

• Position is based in Raritan, NJ and may require up to 15% travel.

Anticipated base pay range: $164,000 to $282,900 USD.

Employees are eligible to participate in company‑sponsored employee benefit programs: medical, dental, vision, life insurance, short‑ and long‑term disability, business accident insurance, group legal insurance, consolidated retirement plan (pension and 401(k)), long‑term…